Idiopathic autonomic neuropathy presents with acute or subacute onset and gradual, incomplete recovery, with features suggesting an immune-mediated mechanism that may warrant early immunosuppressive therapy.
Answers are grounded in this paper and cite their sources.
Supports immune-mediated hypothesis in idiopathic autonomic neuropathy; leaves open role of immunosuppression pending controlled trials.
We evaluated the natural history, electrophysiologic characteristics, spectrum of autonomic involvement, pathology, and laboratory features in 27 patients with idiopathic autonomic neuropathy who were followed up for a mean of 32 months. The typical features of idiopathic autonomic neuropathy include the absence of an associated disease, frequent history of preceding infection, and acute or subacute onset with a monophasic course. The spectrum of autonomic involvement ranges from panautonomic to selective adrenergic or cholinergic failure. There is infrequent involvement of somatic nerve fibers as assessed by routine nerve conduction studies. Pathologic features include the presence of a small inflammatory mononuclear cell infiltrate in the epineurium. Recovery tends to be gradual and frequently incomplete. The acute onset, frequent antecedent viral infection, selectivity of involvement by fiber type and autonomic level, and presence of perivascular mononuclear cell infiltration suggest that the underlying mechanism is likely to be immune-mediated. These observations may justify plasma exchange or other immunosuppressive modalities as early therapeutic intervention in patients with progressive disability.
No takes yet. Share an insight, caveat, or question.
Suárez et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: